Dobrzyńska L, Mierzejewska E, Sokół A
Neurol Neurochir Pol. 1985 May-Jun;19(3):221-6.
The authors present the results of own investigations on the occurrence of side effects following myelography with the contrast medium Amipaque administered usually by the lumbar route. Sixty patients aged 21-65 years with various diseases of the spinal cord and cauda equina were studied. Clinical and myelographic investigations were performed before and after myelography. In 6 out of 60 cases (10%) transient neurological disturbances developed including epileptic seizures, speech disturbances of the type of aphasia and dysartria, visual disturbances and twitching of lower extremities. Other symptoms and signs included: headaches, vomiting, collapse. One patient with cardiorespiratory failure died hours after myelography with evidence of increased symptoms of cardiorespiratory failure. EEG changes appeared after myelography in 2/3 of cases and persisted for up to 12 days. The authors call attention to the high proportion of neurological complications and EEG changes which must be taken into account when indications to myelography are considered. Particular caution is necessary in cases with coexistent cardiorespiratory failure.
作者展示了他们自身关于使用通常经腰椎途径注射的造影剂阿米培克进行脊髓造影后副作用发生情况的调查结果。研究了60例年龄在21至65岁之间患有各种脊髓和马尾疾病的患者。在脊髓造影前后进行了临床和脊髓造影检查。60例中有6例(10%)出现短暂性神经功能障碍,包括癫痫发作、失语和构音障碍类型的言语障碍、视觉障碍以及下肢抽搐。其他症状和体征包括:头痛、呕吐、虚脱。1例患有心肺功能衰竭的患者在脊髓造影数小时后死亡,有证据表明心肺功能衰竭症状加重。2/3的病例在脊髓造影后出现脑电图改变,且持续长达12天。作者提醒注意神经并发症和脑电图改变的高比例情况,在考虑脊髓造影适应证时必须予以考虑。对于并存心肺功能衰竭的病例尤其需要谨慎。